Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline PrEP vs PEP for STI Prevention (DISCO)
NCT04762134Recruiting
- Start
- Jun 2023
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of doxycycline in syphilis, chlamydia infection and gonorrhea (2 arms). Primary endpoint: Plasma doxycycyline levels to determine efficacy of doxycycline chemoprophylaxis at 60 weeks. Started Jun 2023; status: recruiting.
02
Drugs
doxycycline
03
Conditions
syphilischlamydia infectiongonorrhea
Beyond the preview
Go deeper on NCT04762134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04762134.